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Abstract
Background: The purposes of this study are to examine if the human glucocorticoid
receptor (hGR) isoform-α mRNA and hGR protein expressions are deficient in the acute
phase of sepsis (S) compared to systemic inflammatory response syndrome (SIRS) and
healthy subjects (H) and to evaluate if the hGRα and hGR alterations are associated with
cortisol changes and if they are related to (1) extracellular and intracellular heat shock
proteins (HSP) 72 and 90α; (2) ACTH, prolactin, and interleukins (ILs); and (3) outcome.
Methods: Patients consecutively admitted to a university hospital intensive care unit
(ICU) with S (n = 48) or SIRS (n = 40) were enrolled in the study. Thirty-five H were also
included. Total mRNA was isolated from peripheral blood samples and cDNA was
prepared. RT-PCR was performed. Intracellular hGR and HSP expression in monocytes
and/or neutrophils was evaluated using four-colour flow cytometry. Serum prolactin,
ACTH, and cortisol concentrations were also measured. ELISA was used to evaluate
serum ILs and extracellular (e) HSPs (eHSP72, eHSP90α).
Results: hGR protein was higher in S compared to H and SIRS; hGRα mRNA was higher
in S compared to H (p < 0.05). In sepsis, hGR protein and eHSP72 were higher among
non-survivors compared to survivors (p < 0.05). The hGR MFI and hGRα mRNA fold
changes were significantly related to each other (rs = 0.64, p < 0.001). Monocyte
hGR protein expression was positively correlated with extracellular and intracellular
HSPs, cortisol, and ILs and negatively to organ dysfunction (p < 0.05). HSPs, hGR,
and cortisol were able to discriminate sepsis from SIRS (AUROC > 0.85, p < 0.05).
In sepsis, monocyte-hGR protein and eHSP72 were strong predictors of mortality
(AUROC > 0.95, p < 0.04).
Conclusions: Acute-phase sepsis is associated with increased hGR expression and
cortisol concentrations, possibly implying no need for exogenous steroids. At this
stage, hGR is able to predict sepsis and outcome and is related to stress-activated
bio-molecules and organ dysfunction.
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Background
Sepsis is a life-threatening organ dysfunction caused by a dysregulated host re-
sponse to infection [1]. The activation of the hypothalamic–pituitary–adrenal
(HPA) axis results in increased cortisol concentrations driven by increased secre-
tion of ACTH [2]. Also, decreased activity of the cortisol metabolizing enzymes
impairs cortisol clearance, enhances hypercortisolism, and suppresses ACTH secre-
tion by feedback inhibition [3].
In humans, glucocorticoids (GCs) exert their effects through binding to their
cognate receptor, the glucocorticoid receptor, a ligand-dependent transcription fac-
tor [4]. The human glucocorticoid receptor (hGR) is encoded by the NR3C1 gene,
which is located on the long arm of chromosome 5 (5q31.3) and is composed of
ten exons. Alternative splicing of exon nine generates two highly homologous re-
ceptor isoforms, hGRα, and hGRβ. The residing in the cytoplasm hGRα functions
as a ligand-dependent transcription factor [4]. The hGRβ does not bind gluco-
corticoid agonists and exerts a dominant negative effect on the transcriptional
activity of hGRα [5].
In the absence of ligand, the hGRα resides mostly in the cytoplasm of cells as
part of a hetero-oligomeric complex, which contains chaperone heat shock proteins
(HSPs) 90 and 70. HSP90 regulates ligand binding, as well as cytoplasmic retention
of hGRα by exposing the ligand-binding site and masking the two nuclear
localization sequences [4]. HSP90α and HSP72 work together as the only two es-
sential components of the five-protein system for allowing hGRα to bind the
incoming steroid hormone by enhancing its affinity for the ligand [6]. Upon ligand
binding and phosphorylation, the hGRα dissociates from HSPs and translocates
into the nucleus. Nuclear hGRα binds to glucocorticoid response elements (GREs)
of target genes and upregulates or downregulates their expression, depending on
GRE sequence and promoter context [4] (Fig. 1).
GCs downregulate the expression of their receptor through transcriptional, post-
transcriptional, and posttranslational mechanisms [7]. Thus, treatment with GCs
activates a negative feedback loop by inducing a specific critical suppressor of
NR3C1 gene, the microRNA-124, thereby impeding the hGRα upregulation and
shifting the hGRα:hGRβ ratio toward hGRβ. Such a shift limits or negatively im-
pacts the GC anti-inflammatory effects by aggravating the GC resistance [8]. Septic
serum induces the expression of not only hGRα but also of hGRβ in both T and B
cells in culture, supporting a possible GC resistance of specific cell subpopulations
in sepsis [9]. In pediatric sepsis, however, hGRβ mRNA levels did not change
significantly during sepsis, verifying inconsistency with results of hGRβ [10]. By in-
vestigating hGRα mRNA expression rather than protein levels [8], these studies
produced inconsistent results about the hGRα expression and function in critical
illness.
To the best of our knowledge, the assessment of both protein and mRNA hGRα
expression in sepsis and systemic inflammatory response syndrome (SIRS) in rela-
tion to their hetero-oligomeric HSPs parts, and the stress-induced inflammatory re-
sponse has not been investigated previously. In this study, we assessed the hGR
protein expression in monocytes and the hGRα mRNA in whole blood in intensive
care unit (ICU) patients with early-onset sepsis (S) compared to SIRS or healthy
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control subjects (H). We examined the hypothesis that the hormonal-innate im-
mune stress-responding pairs of hGR-cortisol and hGR-HSPs are adequately
expressed in the acute phase of sepsis. We also examined the hypothesis that the
hGR mRNA fold change and protein expression alterations are associated with
simultaneous cortisol, extracellular or intracellular HSP72 or HSP90α changes, or
with stress-activated bio-molecules and organ dysfunction. Finally, we evaluated the
ability of the hGR alterations to predict sepsis or outcome.
Fig. 1 Glucocorticoids (GC) diffuse across the cell membrane and bind to human glucocorticoid receptor
(hGR) in the cytoplasm. In a heat shock protein (HSP) heterocomplex, hGRα is activated (upon ligand binding),
is released from HSP72 and HSP90α, and rapidly translocates into the nucleus, where the transcription of target
genes is initiated. Through transactivation, binding of two hGRα molecules together as a homodimer to
glucocorticosteroid response elements (GRE) in the promoter region of steroid-sensitive genes leads to
the transcription of genes encoding anti-inflammatory mediators (i.e., IL-10) and the inhibition of nuclear
factor-κB (NF-κB). Through transrepression, the hGRα–GC complex interacts with the activated by NF-κB
and other pro-inflammatory transcription factors with intrinsic histone acetyltransferase (HAT) activity
switching off multiple activated inflammatory genes (i.e., IL-6). CBP cAMP response element binding protein,
IKKβ inhibitor of I-κB kinase-β
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Methods
Patients
The study was approved by the institutional review board of Evangelismos Hospital
and was performed during a 24-month period between September 2013 and
September 2015. Written informed consent was obtained from the relatives of pa-
tients admitted to the ICU. Patients aged 18–75 years consecutively admitted with
early-onset (<24 h) sepsis/septic shock or SIRS were eligible for enrollment. The
sepsis group (S) included patients (n = 48) with an identified source of infection
and Sequential Organ Failure Assessment (SOFA) [11] score >2, according to the
updated Sepsis-3 definition [12]. Of those, 59.5% fulfilled the septic shock criteria
(need for inotropic support to maintain MAP > 65 mmHg and lactate levels
>2 mmol/L). The non-infectious SIRS group included trauma patients (n = 40) who
met at least two of the four conventional criteria for SIRS [13] and represented
the first control group (ICU control). The H group included healthy volunteers (n = 35),
representing the second control group (healthy individuals). Exclusion criteria were (a)
malignancy, (b) autoimmune diseases, (c) prior use of corticoids, (d) immune deficiency
disorders, and (e) late sepsis or SIRS > 48 h after admission. Acute Physiology and Chronic
Evaluation-II (APACHE II) [14], multiple organ dysfunction (MODS) [15], Simplified
Acute Physiology Score-III (SAPS III) [16], and SOFA scores were recorded on ad-
mission. Blood samples were obtained at 8 am because of a peripheral CLOCK-
mediated circadian acetylation of the human GR counter-regulating the actions of
diurnally fluctuating cortisol [17]. Blood gas values and clinical laboratory data
were obtained from laboratory records.
Laboratory assays
RNA isolation, reverse transcription and RT-PCR for GRα (NR3C1)
Total RNA was isolated from peripheral blood employing the TRIzol Reagent
(Ambion by Life Technologies) according to the manufacturer’s instructions. RNA
(1 μg) was DNase treated using RQ1 RNase-free DNase (Promega) and reverse
transcription was carried employing the Transcriptor First Strand cDNA Synthesis
Kit (Roche Applied Science). Duplicate samples of the cDNA underwent employing
primers and TaqMan probes designed by TIB MOLBIOL and the LightCycler 480
Probes Master Kit (Roche) on a LightCycler 480 System (Roche). The reference
gene used in this study was the RPLP0. Repeated trials for hGRβ detection in
samples of all groups were mostly unsuccessful, so that only hGRα mRNA was
measured. Standard curves were constructed using triplicate samples of a standard
RNA sample for hGRα and RPLP0. The sequence of the primers and probes of the
target and the reference gene were:
hNR3C1a S 5’-TATgCATgAAgTggTTgAAAATCTCC-3’(exon 9)
hNR3C1a A 5’-ggTATCTgATTggTgATgATTTCAgC-3’ (exon 9)
hNR3C1 FAM-CATCTCggggAATTCAATACTCATggTCTT-BBQ (exon 9)
RPLP0-F 5’-CTCTGGAGAAACTGCTGCCTCATA-3’, (exon 4)
RPLP0-R 5’-GACTTCACATGGGGCAATGG-3’, (exon 5)
RPLP0 FAM-AGGACCTCACTGAGATCAGGGACATGT-BBQ (exon 4-5)
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Data analysis was performed using the Advanced Relative Quantification software
of the LightCycler 480.
Flow cytometry for human GR, HSP72, and HSP90α
The monocytes and neutrophils protein expression was evaluated by flow cytometry.
Ethylenediaminetetraacetic acid (EDTA)-anticoagulated blood (100 μL) was used for flow
cytometric analysis of fresh peripheral blood monocyte (m) and neutrophil (n) HSP72 and
HSP90α, and monocytes hGRα protein expressed as mean fluorescence intensity (MFI)
were determined after staining surface antigens CD33 and CD45 with 5 μL monoclonal
antibodies CD33-PE/Cy5 and CD45 PE/Cy7 (BioLegend, San Diego, USA) followed by
HSP72, HSP90α, and hGR intracellular staining with 5 μL HSP72-FITC, 5 μL HSP90α-
PE, or 10 μL anti-hGR-FITC monoclonal antibodies, respectively (Enzo Life Sciences,
Ann Arbor, MI, USA). Anti-hGRα antibodies conjugated to any fluorescence were not
commercially available. Additionally, although hGR antibody detects all protein isoforms,
hGRα is represented in almost 99% of hGR protein [10]. Non-detection of hGRβ protein
with flow cytometry would also be expected when it couldn’t be detected on RNA level.
Isotype controls were used to check if blocking was needed. Assays were performed
according to the manufacturer’s instructions using Flow Cytometer FC-500 (Beckman
Coulter, Miami, FL, USA).
ACTH cortisol and prolactin
During the first 48 h after admission to ICU, blood samples for determination of
ACTH cortisol and prolactin were collected at 08:00 h. Plasma ACTH was measured
using the Immulite 2000 Immunoassay Analyzer (Siemens Healthcare Diagnostics,
Tarrytown, NY, USA), while serum cortisol and prolactin concentrations were deter-
mined using the ADVIA Centaur Immunoassay Analyzer (Siemens Healthcare Diagnostics,
Tarrytown, NY, USA).
Cytokines and extracellular heat shock proteins
Serum cytokine concentrations of IL-6, IL-10, IL-17, and interferon (IFN)-γ were mea-
sured by ELISA according to the instructions of the manufacturer. Extracellular plasma
levels of HSPs (eHSP72 and eHSP90α) were analyzed by ELISA assay according to the
manufacturers’ instructions (Invitrogen Carlsbad, CA, USA and Enzo Life Sciences,
Ann Arbor, MI, USA, respectively). Inter- and intra-assay confidence intervals (CI) for
each analyte were: IL-6:6.2, 7.8; IL-10:3.25, 2.75 IL-17:3.7 and in process, IFN-γ:3.5, 7.3,
HSP72:7.1, 15.2, HSP90α < 10. Sensitivities of assays: IL-6 < 2 pg/mL, IL-10 < 1 pg/mL,
IL-17 = 2 pg/mL, IFN-γ = 0.03 IU/mL, HSP72 = 90 pg/mL, and HSP90α = 50 pg/mL.
Statistical analysis
The one-sample Kolmogorov–Smirnoff test was used to determine the data distribution
from measured variables. Data are expressed as median values with range for con-
tinuous parameters and as frequencies for categorical variables. The Kruskal–Wallis
independent samples test was used to perform comparisons among groups, as appro-
priate. We ran multiple comparison analyses using post hoc Dunn’s pairwise tests
with Bonferroni corrections for the Kruskal–Wallis H test; the x2 test statistic (H2)
was adopted to calculate the effect size (w2 = H2/(n − 1)) to avoid the inflation of
overall type I error. Between-group comparisons were conducted using the χ2 test
for categorical parameters and Spearman’s rank correlation coefficient for correlation
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between two continuous variables. The effect size for x2 test was measured using the
Cramer’s V (V = √x2/n.df ) goodness of fit. To evaluate predictive values, we
calculated the areas under the receiver operating characteristic curves (AUROC) for vari-
ables significantly differing between S and SIRS groups or between survival and non-
survival sub-cohorts for the sepsis group. For the predictive values of sepsis or mortality
we used biomarkers significantly related to them in bivariate correlations, as appropriate.
We consider an AUROC> 0.80 as clinically relevant whereas the optimum cutoff value
was calculated by the highest sensitivity and specificity combined (Youden index ap-
proach). The positive and negative predictive values were also calculated. A two-sided sig-
nificance level of 0.05 was used for statistical inference. All statistical analyses were
performed using the IBM SPSS Statistics (version 22.0; Chicago, IL).
Results
Group differences
Monocytes hGR protein expression was higher in S compared to H and SIRS
(Kruskal–Wallis Test, pairwise comparisons); hGRα mRNA was higher in S com-
pared to H (Table 1). Groups also differed regarding severity of illness, hormonal,
inflammatory, intracellular, and extracellular innate immune response. The proportions of
variability (effect size) in the ranked dependent variables accounted for by grouping vari-
ables were >0.20 (medium per Cohen), indicating a fairly strong relationship between sep-
sis and the expression levels of hGR protein, cortisol, extracellular HSP72 and 90α, SAPS-
III, IL-6, procalcitonin (PCT), age, sex, and mortality (Table 1).
None of the patients had received steroids the last month before admission (exclusion
criteria). Fifteen S patients had been started on a stress-dose of hydrocortisone before
blood sampling because of catecholamine resistant shock (31%). Neither hGR mRNA
nor MFI differed between the steroid and non-steroid group. Although HSP90α did not
differ between groups, eHSP72 was higher and nHSP72 was lower in the group receiving
hydrocortisone (stress dose). Prolactin concentrations were higher but ACTH were lower
in females compared to males (p < 0.001). Cortisol, hGR, hGRα mRNA, HSPs, and ILs did
not differ between males and females.
Monocytes hGR bivariate correlations
The hGR MFI and hGRα mRNA fold change were significantly related to each other
(rs = 0.64, p < 0.001), even when the hGR protein expression was corrected by the
percentages of WBC monocytes (rs = 0.59, p < 0.01). The expression of hGR pro-
tein in monocytes was related to eHSP90α (rs = 0.33, p < 0.05), eHSP72 (rs = 0.41,
p < 0.02), mHSP90α (rs = 0.60, p < 0.001), nHSP90α (rs = 0.56, p < 0.001), mHSP72
(rs = 0.41, p < 0.02), cortisol (rs = 0.38, p < 0.03), IL-6 (rs = 0.50, p < 0.003), and IL-
10 (rs = 0.40, p < 0.025) (Fig. 2a–j). hGR MFI was also negatively related to PO2
(rs = −0.72, p < 0.02), PO2/FiO2 (rs = −0.76, p < 0.005), and albumin (rs = −0.77, p < 0.01)
and positively to MODS (rs = 0.61, p < 0.01) and SOFA (rs = 0.56, p < 0.03). hGRα
mRNA was related to eHSP72 (rs = 0.34, p < 0.02), ACTH (rs = 0.36, p < 0.005), IFN-
γ (rs = 0.42, p = 0.001), C-reactive protein (CRP) (rs = 0.25, p < 0.05), and WBC (rs = 0.38,
p < 0.002). No significant associations were found between hGRα and APACHE II, SAPS
III, temperature, PCT, IL-17, lactate, LDH, or glucose.
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Mortality
More patients with sepsis died compared to those with SIRS (43.8 vs. 12.5%, p = 0.001)
(Table 1). Within the sepsis group, more patients with septic shock showed a trend
to die compared to those without (56 vs. 29%, p = 0.08). In sepsis group, APACHE
II (p < 0.001), SAPS III (p < 0.02), hGR protein expression in monocytes (p < 0.04),
and eHSP72 (p < 0.05) were higher among non-survivors compared to survivors. In
SIRS, eHSP90α levels (p < 0.02) were higher among non-survivors (Fig. 3a–f ).
Regarding survivors, when septic and SIRS patients were compared, APACHE II
(p < 0.03), SOFA (p < 0.03), SAPS III (p < 0.001), cortisol (p = 0.001), eHSP72 (p < 0.001),
eHSP90α (p < 0.02), IL-6 (p = 0.005), and IL-10 (p < 0.01) were higher among septic com-
pared to SIRS survivors. Regarding non-survivors, SAPS III (p < 0.01), cortisol (p < 0.02),
ACTH (p < 0.04), eHSP72 (p < 0.05), and IFN-γ (p < 0.02) were higher among septic com-
pared to SIRS patients (Fig. 3a–f ).
Fig. 2 Bivariate correlations of monocyte hGR protein (MFI) with a hGRα mRNA (rs = 0.64, p < 0.001); b cortisol
(rs = 0.38, p < 0.03); c eHSP72 (rs = 0.41, p < 0.02); d eHSP90α (rs = 0.33, p < 0.05); e IL-6 (rs = 0.50, p < 0.003); f IL-10
(rs = 0.40, p < 0.025); g mHSP90α (rs = 0.60, p < 0.001); h SOFA score (rs = 0.56, p < 0.03); j PO2/FiO2 (rs = −0.76,
p < 0.005) (Spearman’s rank correlation tests). hGRα human glucocorticoid receptor isoform-α, HSP heat shock
protein, IL interleukin, e extracellular m monocyte, SOFA Sequential Organ Failure Assessment
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Intracellular mHSP72 and nHSP72 were non-significantly decreased in sepsis com-
pared to SIRS, especially among non-survivors. In the septic shock subcohort nHSP72
and nHSP90α were more repressed compared to non-septic shock (p < 0.05), the hGRα
mRNA showing a similar trend.
hGR predictive values
We generated ROC curves for hGR, stress-proteins (HSPs) expressing innate immunity,
and cortisol with the best p values for discriminating sepsis among ICU patients (Fig. 4a)
or predicting mortality in the subpopulation of Sepsis-3 patients (Fig. 4b). Extracellular
HSP72, cortisol, and hGR protein expression in monocyte best-discriminated sepsis from
SIRS as indicated by an AUROC > 0.85 with cutoff values and positive and negative pre-
dictive values presented in Table 2. In the sepsis group only, monocyte-hGR protein ex-
pression and eHSP72 were strong predictors of mortality, achieving an AUROC> 0.95
with cutoff values and positive and negative predictive values presented in Table 3.
Discussion
In this study, we showed that early expression of hGRα mRNA or hGR protein expres-
sion in monocytes is significantly higher in patients with sepsis compared to healthy
Fig. 3 Comparisons between survivors and non-survivors in the sepsis and SIRS subcohorts, regarding a severity
of illness, b hormonal, c glucocorticoid receptor, d extracellular and e intracellular innate immune, and
f inflammatory acute stress response. The p value was calculated using the Mann-Whitney U test and a
p value <0.05 (two sided) was considered statistically significant. Sepsis and/or mortality was associated
with or had a trend for increased severity of illness, expression of extracellular HSP90α and HSP72, cytokines,
cortisol, and GR and a trend for lower intracellular HSP72. Asterisk indicates p < 0.05 between non-survivors and
survivors in each diagnostic group; number sign indicates p < 0.05 between sepsis and SIRS in each outcome
group. SIRS systemic inflammatory response syndrome, APACHE II Acute Physiology and Chronic Evaluation,
SOFA Sequential Organ Failure Assessment, SAPS III Simplified Acute Physiology Score III, GR glucocorticoid
receptor, HSP heat shock protein, IL interleukin, IFN-γ interferon gamma, MFI mean fluorescence intensity
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controls and/or patients with SIRS. Furthermore, we verified the hypothesis that the
hormonal-innate immune stress-responding pairs of hGR-cortisol and hGR-HSPs are
adequately expressed in the early phase of sepsis. We also showed that the hGR mRNA
fold change and protein expression alterations are associated with simultaneous cortisol
and extracellular or intracellular HSP72 or HSP90α changes. It is possible that hGR is
induced in monocytes, in association with the HSPs, to counter-balance the acute in-
flammatory response early in sepsis. We finally showed that in the acute phase of
stress, hGR is able to predict sepsis and outcome and is related with stress-activated
bio-molecules and organ dysfunction.
Our finding of upregulation of monocyte hGR expression could represent an adaptive
response aiming at dampening the aggressive inflammation in early sepsis. This is in
agreement with experimental studies showing increased hGR protein expression and
binding capacity in circulating lymphocytes, monocytes, and splenocytes in murine
endotoxic shock [18]. Earlier studies had shown lower hGRα mRNA trends in sepsis
either in adult T lymphocytes [8] or in neutrophils from children [10] and decreased
Table 2 Receiver operating characteristic curve analysis to determine the optimum cutoff values
and the positive and negative predictive values of hGR, cortisol, and HSPs for the prediction of
sepsis in ICU patients
Parameters
Biomarkers AUROC (95% CI) P value Sensitivity Specificity J Cutoff PPV (%) NPV (%)
eHSP72 0.94 (0.84–1.0) 0.001 0.88 0.79 0.66 0.40 73 68
Cortisol 0.90 (0.77–1.0) 0.002 1.00 0.79 0.79 15.7 66 70
hGR MFI 0.85 (0.69–1.0) 0.008 0.88 0.79 0.66 2.66 73 49
eHSP90α 0.80 (0.62–0.99) 0.02 0.75 0.79 0.54 66.0 72 56
hGRα mRNA 0.75 (0.52–0.98) 0.05 0.75 0.86 0.61 0.38 66 67
Abbreviations: AUROC area under the receiver operating characteristic curve, CI confidence interval, J Youden’s index, PPV
positive predictive value, NPV negative predictive value, eHSP extracellular heat shock protein, hGR human glucocorticoid
receptor, MFI mean fluorescent intensity
Fig. 4 Area under the receiver operating characteristic curve (AUROC) for a discriminating sepsis in ICU
patients: eHSP72, cortisol, and hGR MFI best discriminated sepsis from SIRS as indicated by an AUROC > 0.85;
b AUROC for predicting mortality among patients with sepsis (Sepsis-3 definition): eHSP72 and hGR MFI
were strong predictors of mortality, achieving an AUROC > 0.95. hGRα human glucocorticoid receptor
isoform-α, HSP heat shock protein, MFI mean fluorescence intensity
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3H-dexamethasone binding [19]. Importantly, total and cytoplasmic, but not nuclear,
hGR protein levels were lower in PBMCs from small groups (n = 6–7) of children
with sepsis or trauma compared to controls [20]. Earlier research was only done
on mRNA, which in our study was shown to produce weaker response compared
to protein. Downregulated hGRα in the liver, lung, and spleen but upregulated
hGRα mRNA and binding activity have been reported in muscle in endotoxemic
rats [21]. Inconsistency in selecting cell subpopulations or methods with different
sensitivity in expressing or measuring hGRα might have produced such opposing
results.
Although the anti-inflammatory GC actions have been suggested to be more ef-
fective in males than in females [22], we did not find any sex-specific influence on
hGRα mRNA and hGR-protein expressions, or on serum cortisol, HSP, and ILs
concentrations. Similar to our results, others have also observed that there is no
correlation between hGRα mRNA levels and admission severity of illness [10]. By
generating ROC curves for stress proteins and chaperones, we showed that hGR
protein expression in monocytes, stress-proteins (HSPs) expressing innate immun-
ity, and cortisol could discriminate sepsis among ICU patients with acceptable
positive and negative predictive values. Acknowledging the limitation of the small
sepsis-3 sample, high levels of hGR and eHSP72 were also able to predict mortality
among septic patients. These chaperokines (HSPs), expressing innate-immunity,
and targeted hormone-response receptors (hGR), seem to represent more sensitive
biomarkers in predicting future events than simultaneously calculated or defined
severity of illness scores and shock.
hGRα mRNA is produced much more slowly compared to corresponding hGR
protein expression, translated at the same time [23]. This is because of several
time-consuming steps at RNA processing not required for protein translation. Our
finding, showing a good correlation of hGR protein in monocytes with hGRα
mRNA, is consistent with reports in other human cells and tissues showing that
hGR protein in most cells matches up well with hGRα mRNA levels [24].
Additionally, elevated hGRα mRNA levels correlate with the number of hormone
binding sites in septic rats [25] and human lymphocytes [26], leading to increased
hGRα binding activity and GC sensitivity [27]. Stimulation of T-cells upregulated
the hGRα, possibly rendering T-cells more sensitive to GC, although such a T-cell
response was hindered by hydrocortisone [8]. Such a dynamic impact on the ex-
pression and function of hGRα might possibly explain why GC are beneficial only
when administered early in sepsis [28]. Representing a tissue-specific adaptation,
Table 3 Receiver operating characteristic curve analysis to determine the optimum cutoff values
and the positive and negative predictive values of hGR, cortisol, and HSPs for the prediction of
mortality in ICU patients with Sepsis-3
Parameters
Biomarkers AUROC (95% CI) P value Sensitivity Specificity J Cutoff PPV (%) NPV (%)
hGR MFI 1.00 (1.00–1.0)0 0.034 1.00 0.89 0.89 4.64 66 58
eHSP72 1.00 (1.00–1.00) 0.034 1.00 0.89 0.89 2.1 53 61
eHSP90α 0.79 (0.49–1.00) 0. 23 1.00 0.67 0.67 137.6 44 56
Abbreviations: AUROC area under the receiver operating characteristic curve, CI confidence interval, J Youden’s index, PPV
positive predictive value, NPV negative predictive value, eHSP extracellular heat shock protein, hGR human glucocorticoid
receptor, MFI mean fluorescent intensity
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neutrophil hGRα-binding capacity was decreased in murine sepsis [18] and neutro-
phil hGRα mRNA was decreased in septic children, leading to increased cortisol
resistance of neutrophils, gradually normalized after recovery [10]. This is of par-
ticular importance since the prone to apoptosis during sepsis lymphocytes present
opposing hGRα mRNA regulation from that of the prone to proliferation neutro-
phils. By adopting a whole-blood mRNA approach, we were able to provide a more
comprehensive picture without missing hGR expression signatures from subpopulations
that would potentially have been excluded from the experimental approach [29].
We showed for the first time that hGR protein and/or hGRα mRNA is associ-
ated with the cell chaperokines expressing innate immunity, extracellular and
intracellular HSP72, and HSP90α, besides HPA, IL-6, IL-10, and IFN-γ. Expand-
ing results of previous studies, showing an inverse hGR correlation to noradren-
aline and lactate [28], we found that the hGR was also related with CRP, WBC,
low PO2/FiO2, MODS, and SOFA scores. Although a negative correlation be-
tween hyperthermia and the number of receptors has been previously suggested
[30], we could not find any relation between hGRα and temperature, lactate, glu-
cose, LDH, IL-17, or PCT. In vitro, only heat shock induced mHSP72 and HSP72
mRNA but not lipopolysaccharide [31]. Our findings are in agreement with those
of a recent study showing that in sepsis extracellular HSP72 and HSP90α are in-
creased, while intracellular HSPs are repressed [32]. These data probably imply a
key role for the HSP72 and HSP90α early in sepsis in converting the hGRα to
the steroid-binding state [6]. The hGRα-cortisol or ACTH relations and the
HSP90α time-regulation by the pattern of the pulsatile hormones, further support
such a possibility [33].
The increased prolactin concentrations in our septic patients, have been previously
shown to inhibit cellular immune functions in septic mice, decreasing survival [34], and
to play a role in the acute stress response in sepsis [32]. Generation of cardiotoxic sub-
fragments of prolactin caused by oxidative stress has been implicated in peripartum
cardiomyopathy in women [35]. Although pharmacological blockade of prolactin might
offer an innovative therapeutic intervention, the exact role of prolactin and its relation
to hGRα in sepsis have still to be delineated.
The antibody and methodology used in our study allowed us to measure total
hGR levels without distinction of isoforms, which constitutes a limitation of the
current study. It is not possible to speculate if the higher hGR protein levels repre-
sent proportionally higher hGRβ levels, although we could not detect hGRβ on
RNA level. The correlation of hGR protein with hGRα mRNA suggests that hGR
is mainly representing hGRα, reportedly expressed in extremely higher concentra-
tions than hGRβ [10]. Weak correlations of hGR with some inflammatory, hormo-
nal, or organ failure indices, although significant, should be interpreted with
caution, probably attributed to the small sample numbers. Limitations of this study
are also the lack of longitudinal data and the weakness of a single-center study. An
intact HPA axis and GC response are critical to the host response to infectious
agents. Also, infectious agents may directly modulate GR functioning [36]. The im-
portance of GRα functioning is clearly shown in septic mice lacking endothelial
GRα demonstrating increased mortality, hemodynamic instability, pro-inflammatory
cytokine production [37], and inability to downregulate IL-1β [18]. Our finding of
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increased levels of hGR, cortisol, extracellular HSPs, and cytokines in sepsis, espe-
cially among non-survivors, probably reflects the intensity of the activation of the
HPA axis and acute stress inflammatory and innate-immune response. This increase
might not have been attributed to the cell death, not only since the increased hGR levels
were unrelated to LDH levels but also because the simultaneously measured abundant
intracellular HSP72 and 90 proteins were repressed rather than increased in the sepsis
group and among non-survivors.
GCs may induce apoptosis by directly regulating typical apoptosis or survival genes
or by inducing cellular distress that triggers the apoptotic cascade [38]. Results of this
study indicate that the high-risk patient prepares himself to respond to the “danger”
by increasing the eHSP72, eHSP90α, and cortisol levels in a “ready to bind to an en-
hanced hGR” state. The higher eHSP72 and lower nHSP72 we found in patients re-
ceiving hydrocortisone might probably indicate a higher degree of stress and
inflammation in this group. The positive relations of the hGR to the inflammatory
biomarkers further support this, along with the simultaneous enhanced ACTH and
prolactin, and the organ dysfunction or failure development, when the cell defending
itself represses its bioenergetics. Results of this study, showing that cortisol and hGR
are increased in the acute phase of sepsis, might indicate that cortisol is not “a
limiting factor” early in sepsis. Thus, exogenous cortisol early in sepsis might repress
the already enhanced hGR expression through a negative feedback mechanism, in-
creasing the GC resistance. Although an increased hGR expression has also been
shown in T lymphocytes during septic shock, regardless of GC treatment, hGR binding
capacity was decreased in neutrophils in GC-treated patients [28]. We did not find any
monocyte or whole blood hGR difference between patients started on stress hydrocorti-
sone and those not receiving GCs. The decreased neutrophil capacity to bind hGRα in
sepsis, however, might impede the response to GC treatment. Accordingly, the use of
GCs in septic shock may be dependent on the stage of the sepsis, the reactivity of the
HPA axis, and the sensitivity of hGR to the ligand [36]. Non-steroidal selective hGR
modulators (Sin EGRAMs) that can activate specific hGR mechanisms and thus alter
hGRα-mediated gene expression profiles have now gained more interest using mutant
hGR research [39].
Conclusions
In conclusion, early expression of hGRα mRNA or hGRα protein is significantly
higher in patients with sepsis compared to healthy controls and/or patients with
SIRS. Early in critical illness, the hGR expression can predict sepsis and outcome
and is related with stress-activated bio-molecules and organ dysfunction. It is pos-
sible that the hGR, in association with the HSPs, is induced in monocytes to facili-
tate the cortisol binding to counter-balance the increased inflammatory response to
the acute stress in early sepsis. Exogenous cortisol in the acute phase of sepsis
might decrease the hGR expression through a negative feedback mechanism, in-
creasing the GC resistance. Hopefully, smart research might in future lead to a
more individualized approach to GC treatment in sepsis and septic shock, taking
into account both the hGRα expression and binding capacity, as well as the bal-
ance of the immune-hormonal response.
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Publication of clinical datasets
Our dataset contains clinical data, for which we had undertaken an ethical and
legal responsibility to respect participants’ rights to privacy and to protect their
identity. The already received informed consents from participants at the point of
recruitment to the trial did not mention any consent for publishing raw data. The
institutional review board of Evangelismos Hospital had also demanded all data to
be kept privately and not to be distributed. We should have known this possibility
to include in our initial project and consent, which, however, we did not know. It
is impossible now for the dataset to be considered for publication, because we may
compromise anonymity or confidentiality or breach local data protection laws
regarding patients’ and healthy individuals’ data. Patients and controls in an institu-
tion in a small period are well known, and it is now impossible to obtain a retro-
spective consent regarding publication of data.
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